乳腺导管原位癌(ductal carcinoma in situ,DCIS)是指肿瘤局限于乳腺导管系统,未侵犯基底膜和周围间质阶段的乳腺癌,DCIS是浸润性导管癌的非专一性前体阶段,在此阶段肿瘤不具备浸润特性,不具有进入局部脉管造成转移的能力。理论上,真正的DCIS不应发生腋窝淋巴...
DCIS = ductal carcinoma in situMLO = mediolateral obliqueSynonyms Intraductal carcinoma; Pre-invasive breast cancer; Non-invasive breast cancer; In situ breast cancer; DCIS Definition Ductal Carcinoma in situ (DCIS) is a pre-invasive breast cancer . The malignant cells remain confined behind an ...
Ductal carcinoma in situ (DCIS) is a heterogeneous entity, with a wide range of histological appearances including different architectural growth patterns, different nuclear morphology ranging from minimal to severe nuclear atypia, and the presence or absence of necrosis and calcification. Diagnostic ...
ductal carcinoma in situ释义 常用 牛津词典 释义 [医]原位管癌;双语例句 全部 1. Treatment of ductal carcinoma in situ . [ comment ] . 治疗 乳腺 导管内癌. 来自互联网 2. Objective To study radiologic ( molybdenum target X - ray ) findings of ductal carcinoma in situ ( DCIS ) of breast....
Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, accounts for 1 of every 5 new breast cancer diagnoses. It's an uncontrolled growth of cells within the breast ducts. It’s noninvasive, meaning it hasn’t grown into the breast tissue outside of the ducts. The phrase ...
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Mol Oncol 2010;4:357-68.Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Borresen-Dale AL, Sorlie T, Warnberg F: Molecular diversity in ductal carcinoma...
Ductal carcinoma in situ (DCIS) is mostly diagnosed by mammography. The incidence is between 1% and 5% in countries without widespread use of mammography, but the incidence in mammography screening programs is between 8% and 25%. However, DCIS can also be diagnosed by galactography in patients...
Ductal carcinoma in situ (DCIS) is a noninvasive breast disease that variably progresses to invasive breast cancer (IBC). Given the unpredictability of this progression, most DCIS patients are aggressively managed similar to IBC patients. Undoubtedly, this treatment paradigm places many DCIS patients ...
网络释义 1. 导管原位癌 36个乳腺恶性肿瘤包括:侵润性导管癌26个,导管原位癌(ductal carcinoma in situ DCIS)4个,DCIS伴微浸润1个,粘液腺癌… www.cz96130.com|基于6个网页 2. 乳腺导管内原位癌 患有乳腺导管内原位癌(ductal carcinoma in situ DCIS)的女性,如果其HER2/neu原癌基因编码表达产生的蛋白质水平...
Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive breast cancer (IBC). Studies have indicated differences in DCIS outcome based on race or ethnicity, but molecular differences have not been investigated. We examined the molecular pr